Pharma Pulse 3/14/25: Pre-Launch Prep for Emerging Biopharmas, Using the Power of Three to Simplify the Business of Healthcare & more

Pre-Launch Prep for Emerging Biopharmas: Data First, Then the Rest

Making early commercial data and analytics decisions for launch cen future-proof their data management.

The Power of Three To Help Simplify the Business of Healthcare

The healthcare industry faces unprecedented complexity impacting business stakeholder operations, from managing extensive documentation requirements to protecting sensitive patient data and ensuring accurate payment processing. These challenges create significant inefficiencies that impact not only payers and providers but also the quality, outcomes, and accessibility of patient care. As administrative burdens grow, providers spend less time with patients, security risks threaten data integrity, and payment complications may cause greater administrative costs as well as crucial delays in revenue.

Metals Mayhem Hits American Manufacturing and Trade Ties

On today’s Big Take DC podcast: The impact Trump’s metals tariffs could have on the US economy and its relationships with some of its closest allies.

Crown Bioscience Appoints John Gu as Chief Executive Officer

Crown Bioscience has appointed John Gu as its new Chief Executive Officer. Following his tenure as interim CEO and his role as chief operating officer, John Gu is recognized as an esteemed leader with broad business acumen and extensive experience in digital strategy, business transformation, and genomic data analysis.

Cencora on LinkedIn

John Arena, SVP Enterprise Strategy & Solutions, spoke with Pharmaceutical Commerce Magazine on the critical importance of engaging with partners early in the product development process to ensure a seamless launch.

Watch the interview: https://ow.ly/xXMH50VgPIE

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs